Alpha Cognition Inc. Reports Third Quarter 2026 Financial Results and Provides Operational Update
Alpha Cognition Inc. (NASDAQ:ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing and commercializing novel therapeutics for debilitating neurodegenerative disorders, today reported financial results for the third quarter ended September 30, 2026, and provided…